Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Enzymotec and Il Dong Sign Agreement in the Korean Market
Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- Natural Products Association Announces Opening of China Office
Association announces the opening of a branch office in Beijing, China to better assist the U.S. companies that hope to export their products to this booming marketplace.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- USANA Reports Q2 Results
Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year.
- USANA Reports Q2 Results
Company reports consolidated net sales of $93.9 million, compared with $82.0 million in the second quarter of the prior year, with net earnings of $15.4 million, or 16.4% of net sales, compared with $14.7 million, or 18.0% of net sales, in the second quarter of the prior year.
- Allimax Enters Australia
Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements.
- Allimax Enters Australia
Company announces strategic partnership with Vitasearch PTY LTD. Waterloo, NSW for the development and marketing of its Allimax stabilized allicin extract brand of supplements.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Company announces the appointment of Kevin McDonnell to the position of Executive Vice President, Chief Financial Officer.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- Whole Foods Market Reports Third Quarter Results
Company reported that sales increased 18% to $1.3 billion driven by 14% weighted average square footage growth and 9.9% comparable store sales growth, while net income increased 33% to $53.9 million, and diluted earnings per share increased 27% to $0.37.
- Whole Foods Market Reports Third Quarter Results
Company reported that sales increased 18% to $1.3 billion driven by 14% weighted average square footage growth and 9.9% comparable store sales growth, while net income increased 33% to $53.9 million, and diluted earnings per share increased 27% to $0.37.
- Nu Skin Enterprises Receives Direct Selling Authorization in Mainland China
Company has received approval from the Chinese Ministry of Commerce to commence direct selling activities in Mainland China.
- Nu Skin Enterprises Receives Direct Selling Authorization in Mainland China
Company has received approval from the Chinese Ministry of Commerce to commence direct selling activities in Mainland China.
- Nu Skin Enterprises Reports Second-Quarter 2006 Results
Company reports revenue of $284.1 million, compared to $310.1 million for the prior-year period, with net income and earnings per share for the quarter of $14.1 million and $0.20, respectively, compared to net income of $22.8 million and earnings per share of $0.32 for the same period in 2005.
- Nu Skin Enterprises Reports Second-Quarter 2006 Results
Company reports revenue of $284.1 million, compared to $310.1 million for the prior-year period, with net income and earnings per share for the quarter of $14.1 million and $0.20, respectively, compared to net income of $22.8 million and earnings per share of $0.32 for the same period in 2005.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Balchem Announces Second Quarter Earnings
Company reports net sales of $25.1 million versus $19.5 million the prior year, as the sales of the Encapsulated/Nutritional Products segment were a record $10.5 million, an increase of 55.3% from the prior year comparable quarter.
- Balchem Announces Second Quarter Earnings
Company reports net sales of $25.1 million versus $19.5 million the prior year, as the sales of the Encapsulated/Nutritional Products segment were a record $10.5 million, an increase of 55.3% from the prior year comparable quarter.
- DNP International Reports First Half and Outlook
Company observes adjusted sales increase of over 51%.
- DNP International Reports First Half and Outlook
Company observes adjusted sales increase of over 51%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- PacificHealth Laboratories, Inc. Announces 2nd Quarter Results
Company reports revenues of $1,747,206 compared to revenues of $2,042,382 in the same period last year, with a net loss of ($26,174), or ($0.00) per share, compared to a net loss of ($407,350), or ($0.04) per share, for the same period last year.
- PacificHealth Laboratories, Inc. Announces 2nd Quarter Results
Company reports revenues of $1,747,206 compared to revenues of $2,042,382 in the same period last year, with a net loss of ($26,174), or ($0.00) per share, compared to a net loss of ($407,350), or ($0.04) per share, for the same period last year.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Herbalife Ltd. Reports Second-Quarter Results
Company reports second-quarter net sales of $466.0 million, largely attributable to increases in the company's three largest regions, the Americas, Asia Pacific, and Europe, which achieved net sales growth of 39.2 percent, 24.7 percent, and 2.4 percent, respectively, versus the second quarter of 2005. For the quarter ended June 30, 2006, the company reported net income of $36.3 million, or $0.49 per diluted share, compared to $22.8 million, or $0.32 per diluted share in the second quarter of 2005.
- Herbalife Ltd. Reports Second-Quarter Results
Company reports second-quarter net sales of $466.0 million, largely attributable to increases in the company's three largest regions, the Americas, Asia Pacific, and Europe, which achieved net sales growth of 39.2 percent, 24.7 percent, and 2.4 percent, respectively, versus the second quarter of 2005. For the quarter ended June 30, 2006, the company reported net income of $36.3 million, or $0.49 per diluted share, compared to $22.8 million, or $0.32 per diluted share in the second quarter of 2005.
- Wild Oats Markets, Inc. Reports Second Quarter and First Half 2006 Results
Company reports net sales of $296.6 million, up 4.2 percent compared with $284.6 million in the second quarter of 2005, with net income of $4.9 million, or $0.16 per diluted share, compared with net income of $0.9 million, or $0.03 per diluted share, in the same period last year.
- Wild Oats Markets, Inc. Reports Second Quarter and First Half 2006 Results
Company reports net sales of $296.6 million, up 4.2 percent compared with $284.6 million in the second quarter of 2005, with net income of $4.9 million, or $0.16 per diluted share, compared with net income of $0.9 million, or $0.03 per diluted share, in the same period last year.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
|
DALLAS--(BUSINESS WIRE)--July 31, 2006--Natural Health Trends Corp. (NASDAQ: BHIP - News), a leading international direct selling company, today announced the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31. Ms. Hayano will also join the company's Board of Directors. The CEO position had been vacant since April 2006.
Ms. Hayano, 52, has significant experience in marketing, sales and operations management of mass and direct marketed products. She was selected for the NHT position because of her extensive and successful track record managing corporate turnarounds and leading diverse, international management teams. Most recently, she was the president of her own consulting company where she executed brand re-positionings, distribution strategies and marketing plans on a global level.
Previously, Hayano was general manager and COO of the Personal Care Division of Cosmopolitan Cosmetics, a $150 million division of Proctor & Gamble's Wella unit, where she led a new management team that turned around an unprofitable cosmetics division. Prior to Cosmopolitan, she was executive vice president of AM Products, a $120 million manufacturer of value-driven cosmetics products and oversaw a major reorganization of the company. From 1993 until 1999, Ms. Hayano served as vice president of marketing for Del Laboratories' "Sally Hansen" and "Naturistics" brands where she achieved market leadership for "Sally Hansen" and introduced one of the first families of natural brand products to the mass market.
Ms. Hayano began her career with Estee Lauder in operations and transitioned to manager of international marketing in the late 1970's. She went on to serve as director of global marketing for Halston/Orlane; vice president of worldwide business planning and strategic development for Parfums Sterns, a division of Avon Products; and vice president of business development and acting general manager at La Prairie.
"Stephanie Hayano is a proven executive with an exceptional blend of product marketing, sales, business and leadership skills," said Randall A. Mason, chairman of the board of Natural Health Trends. "She has the experience and vision to take us to the next level of growth while leveraging the company's core entrepreneurial spirit," he continued. Colin O'Brien, the director who chaired NHT's search committee, added that "Stephanie was clearly the best choice for the CEO position and her proven track record of revitalizing product and sales-driven companies will be instrumental in achieving significant growth for our world-wide sales teams."
Ms. Hayano commented: "Natural Health Trends has a unique business model that rewards both the distributor and the customer with opportunity to improve their lives through the sale and use of our products. It enables our distributors to realize their dreams of financial security through a dynamic direct selling organization. This direct route to the consumer, I believe, is the future in personal care products. I am comfortable that my strong product, marketing and management skills combined with an industry-leading sales force can help take the company to its full potential, while maintaining its entrepreneurial spirit. I look forward to working with the seasoned management team already in place," she said.
A native of New York, Ms. Hayano earned her Bachelor of Arts degree from Cornell University where she majored in physics and minored in business.
About Natural Health Trends Corp.
Natural Health Trends Corp. is an international direct-selling company operating through its subsidiaries in 15 countries throughout Asia, North America, Europe and Latin America. The Company markets premium quality personal care products under the NHT Global (formerly Lexxus International) brand. Additional information can be found on the Company's Website, and management encourages interested parties to register for updated corporate information via e-mail on the Company's homepage, www.naturalhealthtrendscorp.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 - Forward-looking statements in this release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. Such statements may relate, among other things, to our relationship with our distributors; our need to continually recruit new distributors; our internal controls and accounting methods that may require further modification; regulatory matters governing our products and network marketing system; our ability to recruit and maintain key management; adverse publicity associated with our products or direct selling organizations; product liability claims; our reliance on outside manufacturers; risks associated with operating internationally, including foreign exchange risks; product concentration; dependence on increased penetration of existing markets; the competitive nature of our business; and our ability to generate sufficient cash to operate and expand our business. For a more detailed discussion of the risks and uncertainties of our business, please refer to our Annual Report on Form 10-K and our amended Annual Report on Form 10-K/A for the fiscal year ended December 31, 2005 filed with the Securities and Exchange Commission. We assume no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein. |